|
Index of reports
> Cases resulting in hospitalization (103)
Below is the selection of adverse event reports related to Altace (Ramipril) that includes cases resulting in hospitalization.
Reports 1 - 25 of 103 Next >>
Adverse event in receiving Altace (Ramipril)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-31
Patient:
Adverse reactions / side effects: Renal Failure, Vomiting, Dehydration, Hypotension, Abdominal Distension, Circulatory Collapse, Pancreatitis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Indication: Hypertension
Simvastatin
Dosage: 40 mg, qd
Administration route: Oral
Indication: Hypercholesterolaemia
Clozapine
Administration route: Oral
Zaponex
Administration route: Oral
Other drugs received by patient: Amisulpride; Atenolol; Aspirin
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-10-22
Patient:
Adverse reactions / side effects: Cryptogenic Organising Pneumonia, Dyspnoea, Eosinophilic Pneumonia, Bronchomalacia, Asthenia, Cough
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 5 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2006-11-15
End date: 2007-01-15
Tenormin
Dosage: 1 u, qd
Administration route: Oral
Start date: 2006-11-15
End date: 2007-06-13
Kardegic / 00002703 /
Dosage: 160 mg, qd
Administration route: Oral
Indication: Prophylaxis
Start date: 2006-11-15
Tahor
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2006-11-15
Plavix
Dosage: 75 mg, qd
Administration route: Oral
Indication: Prophylaxis
Start date: 2006-11-15
End date: 2007-01-15
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-10-22
Patient:
Adverse reactions / side effects: Cardiac Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 5 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-07-10
Metoprolol Succinate
Dosage: 100 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-07-10
Other drugs received by patient: Trombyl; Simvastatin
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-10-18
Patient:
Adverse reactions / side effects: HIP Fracture, Fall, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 1.25 mg, qd
Administration route: Oral
Indication: Hypertension
End date: 2007-06-18
Burinex
Dosage: 5 mg, qd
Administration route: Oral
Indication: Cardiac Failure
End date: 2007-06-18
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-10-17
Patient:
Adverse reactions / side effects: Hypotension, Rectal Haemorrhage, Gastric Ulcer
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 1 u, qd
Administration route: Oral
Indication: Hypertension
Lasix
Dosage: 40 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Previscan / 00789001 /
Dosage: 25 mg, qd
Administration route: Oral
Indication: Thrombosis
End date: 2006-10-13
Previscan / 00789001 /
Start date: 2006-10-15
Aldactone
Dosage: 1 u film-coated tablet
Administration route: Oral
Indication: Cardiac Failure
Elisor
Dosage: 1 u tablet,qd
Administration route: Oral
Indication: Hypercholesterolaemia
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-10-15
Patient:
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Jaundice, Scratch, Pruritus, Alanine Aminotransferase Increased, Impetigo, Glomerulonephritis Membranous, Hepatitis Cholestatic, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: unk, qd
Administration route: Oral
Start date: 2006-06-15
End date: 2007-06-10
Chloraminophene
Dosage: 12 mg, qd
Administration route: Oral
Indication: Glomerulonephritis
Start date: 2007-02-15
End date: 2007-03-15
Tahor
Dosage: 20 mg, unk
Administration route: Oral
Start date: 2006-06-15
End date: 2007-06-10
Effexor / 01233802 /
Dosage: unk, qd
Start date: 2006-06-15
End date: 2007-06-10
Other drugs received by patient: Aldactone; Lasix; Levothyrox
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Russian Federation on 2007-10-11
Patient:
Adverse reactions / side effects: Pain in Extremity, Intermittent Claudication
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace (Ramipril)
Other drugs received by patient: Crestor
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from Norway on 2007-10-10
Patient:
Adverse reactions / side effects: Hyperkalaemia, Nausea, General Physical Health Deterioration, Acidosis, Abdominal Pain Upper, Blood Glucose Decreased, Dehydration, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Altace (Ramipril)
Other drugs received by patient: Atrovent; Nexium; Glimepiride; Glucophage; Lipitor; Burinex
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-10-05
Patient:
Adverse reactions / side effects: Phlebitis, Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 1.25 mg, qd
Administration route: Oral
Indication: Nephrotic Syndrome
Lasix
Dosage: unk, qd
Administration route: Oral
Indication: Nephrotic Syndrome
Thalidomide
Dosage: 200 mg, qd
Administration route: Oral
Indication: Multiple Myeloma
Aldactone
Dosage: 75 mg, qd
Administration route: Oral
Indication: Nephrotic Syndrome
Other drugs received by patient: Alkeran; Dexamethasone 0.5mg TAB; Previscan / 00789001 /
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-10-01
Patient:
Adverse reactions / side effects: HIP Fracture, Fall, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 1.25 mg, qd
Administration route: Oral
Indication: Hypertension
End date: 2007-06-18
Burinex
Dosage: 5 mg, qd
Administration route: Oral
Indication: Cardiac Failure
End date: 2007-06-18
Adverse event in female receiving Altace (Ramipril)
Reported by a pharmacist from Canada on 2007-07-31
Patient: female, weighing 77.1 kg (169.6 pounds)
Adverse reactions / side effects: Carpal Tunnel Syndrome
Adverse event resulted in: hospitalization
Suspect drug(s):
Lipitor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2007-05-18
End date: 2007-06-22
Metoprolol Succinate
Administration route: Oral
Indication: Angina Pectoris
Altace
Dosage: daily dose:2.5mg
Administration route: Oral
Indication: Angina Pectoris
Altace
Indication: Hypertension
Plavix
Other drugs received by patient: Aspirin
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-07-30
Patient:
Adverse reactions / side effects: Syncope, Atrial Fibrillation, Blood Potassium Increased, Blood Creatinine Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Start date: 2006-12-15
End date: 2007-06-20
Atacand
Dosage: 4 mg, qd
Indication: Cardiac Failure
Start date: 2007-04-18
End date: 2007-05-02
Atacand
Dosage: 8 mg, qd
Administration route: Oral
Start date: 2007-05-03
End date: 2007-06-20
Spironolactone
Dosage: 50 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-01-18
End date: 2007-06-20
Spironolactone
Dosage: 12.5 mg, qd
Administration route: Oral
Start date: 2007-06-21
Other drugs received by patient: Behepan; Zolpidem Tartrate; Imodium / 00384302 /
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-07-26
Patient:
Adverse reactions / side effects: LOW Cardiac Output Syndrome, Vomiting, Dyspnoea, Hyperkalaemia, Drug Interaction, Haemodialysis, Cardiac Failure, Renal Tubular Necrosis, Hypoperfusion, Blood Creatinine Increased, Renal Failure Acute, Anuria
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Administration route: Oral
End date: 2007-05-08
Lasilix / 00032601 /
Administration route: Oral
End date: 2007-05-08
Cordarone / 00133102 /
Dosage: 200 mg, unk
Administration route: Oral
Aldactone
Administration route: Oral
End date: 2007-05-08
Celebrex
Administration route: Oral
Indication: Pain in Extremity
Other drugs received by patient: Previscan / 00789001 /
Adverse event in receiving Altace (Ramipril)
Reported by a physician from United Kingdom on 2007-07-25
Patient:
Adverse reactions / side effects: Myalgia, Musculoskeletal Discomfort, Paraesthesia, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace (Ramipril)
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United Kingdom on 2007-07-24
Patient:
Adverse reactions / side effects: Mental Impairment, Orthostatic Hypotension, Dizziness
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Furosemide / 00032601 /
Dosage: 60 mg, unk
Furosemide / 00032601 /
Dosage: 40 mg, unk
Bisoprolol Fumarate
Dosage: 5 mg, unk
Bisoprolol Fumarate
Dosage: 1.25 mg, unk
Other drugs received by patient: Crestor
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Germany on 2007-07-23
Patient:
Adverse reactions / side effects: Atrial Flutter, Tachyarrhythmia, Drug Interaction Potentiation, Atrial Fibrillation, Fall, Syncope, Palpitations, Dizziness, Unevaluable Event, Asthenia, Blood Pressure Decreased, RIB Fracture
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 5 mg, qd
Administration route: Oral
Start date: 2006-02-01
Seroquel
Dosage: 150 mg, qd
Administration route: Oral
Start date: 2007-02-15
End date: 2007-02-15
Seroquel
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2007-02-16
End date: 2007-02-16
Seroquel
Dosage: 450 mg, qd
Administration route: Oral
Start date: 2007-02-17
End date: 2007-02-17
Seroquel
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2007-02-18
End date: 2007-02-19
Seroquel
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2007-02-20
End date: 2007-02-21
Norvasc
Dosage: 5 mg, qd
Administration route: Oral
Start date: 2007-02-15
End date: 2007-02-17
Other drugs received by patient: Lorazepam; Lorazepam; Pantazol
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from Germany on 2007-07-19
Patient:
Adverse reactions / side effects: Vomiting, Nausea, Blood Potassium Decreased, Dizziness, Hyponatraemia, Unevaluable Event
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Start date: 2006-09-01
Nexium
Dosage: 20 mg, qd
Administration route: Oral
Start date: 2006-11-27
Carbamazepine
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2006-11-27
End date: 2006-11-27
Carbamazepine
Dosage: 1100 mg, qd
Administration route: Oral
Start date: 2006-11-28
End date: 2006-11-28
Carbamazepine
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2006-11-29
End date: 2006-11-29
Disalunil
Dosage: 50 mg, qd
Administration route: Oral
Start date: 2006-09-01
End date: 2006-11-28
Disalunil
Dosage: 25 mg, qd
Administration route: Oral
Start date: 2006-11-29
End date: 2006-11-30
Other drugs received by patient: Trimipramine Maleate; Protaphane MC / 00030504 /; Insulin MC Actrapid
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Norway on 2007-07-18
Patient:
Adverse reactions / side effects: Coeliac Disease, Enteritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Indication: Congestive Cardiomyopathy
Start date: 2003-01-01
Altace
Indication: Cardiac Failure
Altace
Indication: Arrhythmia
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from Spain on 2007-07-17
Patient:
Adverse reactions / side effects: Hyperkalaemia, Drug Interaction, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 20 mg, qd
Administration route: Oral
Indication: Essential Hypertension
End date: 2007-04-10
Cozaar
Dosage: 100 mg, qd
Administration route: Oral
Indication: Hypertension
End date: 2007-04-10
Iodate Contrast
Start date: 2007-04-01
End date: 2007-04-01
Other drugs received by patient: Coropres; Tromalyt; Prevencor / 01326102 /
Adverse event in receiving Altace (Ramipril)
Reported by a physician from United States on 2007-07-17
Patient:
Adverse reactions / side effects: Vomiting, Haemorrhage Intracranial, Hypotension, Mental Status Changes, Neurological Examination Abnormal, Fall, Dysarthria, Skin Laceration, Syncope
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Warfarin Sodium
Dosage: 3.7 mg, qd
Start date: 2006-09-12
Norvasc
Toprol-XL
Oxycodone HCL
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-07-16
Patient:
Adverse reactions / side effects: Hyperkalaemia, Bundle Branch Block Right, Bundle Branch Block Left, Fall, Sinus Bradycardia, Grand MAL Convulsion, Lung Disorder, Malaise, Protein Total Increased, Pulmonary Oedema, Blood Creatinine Increased, Sinoatrial Block, Renal Failure Acute, Anuria
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Altace
Dosage: 2.5 mg, qd
Administration route: Oral
End date: 2007-05-09
Cardensiel
Dosage: 2.5 mg, qd
Administration route: Oral
End date: 2007-05-09
Pravidual
Dosage: 40 mg, qd
Administration route: Oral
End date: 2007-05-09
Other drugs received by patient: Previscan / 00789001 /; Metformin HCL; Lasilix / 00032601 /
Adverse event in 68 year old male receiving Altace (Ramipril)
Reported by a physician from United States on 2007-07-11
Patient: 68 year old male, weighing 93.0 kg (204.6 pounds)
Adverse reactions / side effects: LIP Swelling, Angioedema, Swelling Face, Chest Pain, Oedema Peripheral, Testicular Swelling, Throat Tightness
Adverse event resulted in: hospitalization
Suspect drug(s):
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-11-01
End date: 2007-02-01
Januvia
Administration route: Oral
Start date: 2007-05-01
Altace
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2003-07-21
End date: 2007-02-01
Altace
Administration route: Oral
Indication: Cardiac Disorder
Start date: 2003-07-21
End date: 2007-02-01
Other drugs received by patient: Avandamet; Caduet; Aspirin
Adverse event in receiving Altace (Ramipril)
Reported by a physician from France on 2007-07-05
Patient:
Adverse reactions / side effects: Sideroblastic Anaemia, Chronic Myelomonocytic Leukaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2004-10-01
End date: 2005-05-01
Altace
Dosage: 5 mg, qd
Administration route: Oral
Start date: 2005-04-30
End date: 2007-01-12
Other drugs received by patient: Sintrom; Lipanor; Digoxin; Amlodipine; Josir
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-06-27
Patient:
Adverse reactions / side effects: Weight Decreased, Blood Urea Increased, Vomiting, Nausea, Abdominal Pain Upper, Anorexia, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Essential Hypertension
End date: 2007-03-28
Aldactone
Dosage: 75 mg, qd
Administration route: Oral
Indication: Essential Hypertension
End date: 2007-03-28
Other drugs received by patient: Kardegic / 00002703 /; Lasilix / 00032601 /
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from Switzerland on 2007-06-26
Patient:
Adverse reactions / side effects: Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Alanine Aminotransferase Increased, Bone Pain, General Physical Health Deterioration, Cholestasis, Cardiac Failure Acute, Aspartate Aminotransferase Increased, Pleural Effusion, Sinus Tachycardia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Dosage: 1.25 mg, qd
Administration route: Oral
Start date: 2007-03-31
End date: 2007-04-13
Tazobac / 01173601 /
Dosage: 4.5 g, tid
Indication: Pneumonia Bacterial
Start date: 2007-03-26
End date: 2007-04-04
Augmentin / 00756801 /
Dosage: 1.2 g, bid
Indication: Pneumonia Bacterial
Start date: 2007-03-25
End date: 2007-03-26
Other drugs received by patient: Duragesic-100; Haldol Solutab; Seresta; Fragmin / 01708302 /; Torem / 01036501 /; K CL TAB; Dafalgan / 00020001 /; Zofran; Nexium; FIG Syrup
Page 1 Next >>
|
